Current strategies and findings in clinically relevant post-translational modification-specific proteomics

Area of Science:

• Biochemistry and Molecular Biology
• Proteomics
• Clinical Research

Background:

• Mass spectrometry-based proteomics has significantly advanced the understanding of protein post-translational modifications (PTMs) and their dynamics.
• Quantitative proteomics has primarily focused on cell culture models, revealing insights into PTM dysregulation in human diseases.
• Technological advancements enable PTM-specific proteomic studies on limited clinical samples.

Purpose of the Study:

• To discuss PTMs relevant to clinical research, including phosphorylation, glycosylation, and proteolytic cleavage.
• To provide an overview of current developments and novel findings in mass spectrometry-based PTM research.
• To highlight the potential of quantitative proteomics for biomarker discovery and validation in clinical settings.

Main Methods:

• Mass spectrometry-based proteomics
• Quantitative proteomics
• PTM enrichment strategies
• Analysis of clinical samples (body fluids, tissues)

Main Results:

• Demonstrated the utility of proteomics for studying PTMs in clinical samples.
• Identified key PTMs (phosphorylation, glycosylation, proteolytic cleavage) relevant for clinical research.
• Highlighted the potential for biomarker discovery and quantification using PTM-specific proteomic approaches.

Conclusions:

• Quantitative proteomics offers significant potential for discovering, validating, and quantifying biomarkers in clinical samples.
• Integration of robust proteomics technology into clinical environments is crucial for advancing personalized medicine.
• Continued development in mass spectrometry-based PTM research will yield novel insights into disease mechanisms and diagnostics.